Latest Research

In recent weeks we have seen three of the leading medical institutions, The American Medical Association (AMA), the Undersea and Hyperbaric Medical Society (UHMS) and the U.S. Food and Drug Administration (FDA) issued statements formally acknowledging the use of mild hyperbaric oxygen therapy as unsafe in certain settings due to the dangers of fire and…

As the SARS-Cov-2 (COVID-19) pandemic continues worldwide. It continues to remain a major global public health issue, however, we are seeing positive results across two case studies measuring the effectiveness of Hyperbaric Oxygen Therapy (HOBT) as an adjunct treatment for COVID-19. It has yet to be determined if HBOT will become an approved treatment option…

The movement for a physiologic and biochemical rationale The SARS-Cov-2 (COVID-19) pandemic continues worldwide. It remains a major global public health issue, with variants arising to challenge the medical community’s efforts. Improved supportive and anti-inflammatory intervention – which often employs known drugs or technologies – has provided measurable improvement in management. Plus, we have recently…

Hyperbaric oxygen (HBO2) is a commonly used treatment for patients who have suffered the late effects of radiation therapy, also known as Chronic Radiation Tissue Injury (CRTI) or Soft Tissue Radionecrosis (STRN). While we utilize radiation to kill cancer cells, it also damages healthy tissue that is next to the cancer. Radiation results in tissue…

Hyperbaric Oxygen (HBO2) HBO2 has been used to treat a variety of different diseases that all have hypoxia – a lack of oxygen – as a common denominator. HBO2 has been shown to stimulate new blood growth and enhance the body’s ability to kill bacteria by increasing the amount of oxygen in the body ten-fold…